Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Go back to Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders| (AMEX: MBCOF) | Delayed: 0.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.07 | 52 Week High | $ | |||
| Open | $0.07 | 52 Week Low | $ | |||
| Day High | $0.07 | P/E | N/A | |||
| Day Low | $0.07 | EPS | $ | |||
| Volume | 5,697 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 229.46 -7.63 (3.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.09 | 52 Week High | $13.61 | |||
| Open | $232.45 | 52 Week Low | $7.40 | |||
| Day High | $233.75 | P/E | 358.53 | |||
| Day Low | $229.32 | EPS | $0.64 | |||
| Volume | 1,384,224 | |||||



